Immunohistochemical expression of anti-apoptotic protein bcl2 and its correlation with hormone receptors in breast cancers
Objectives One of the novel benefits of immunohistochemistry in human malignancy (in addition to its major role in confirming the diagnosis) is to discover specific therapeutic targets in cancer cells, so this study was conducted to identify immunohistochemical expression of bcl2 in breast cancers,...
Main Authors: | Haider Latteef Mohammed, Farah Falah Hassan Abu Deka |
---|---|
Format: | Article |
Language: | English |
Published: |
Nab'a Al-Hayat Foundation for Medical Sciences and Health Care - Press
2018-03-01
|
Series: | Iraq Medical Journal |
Online Access: | http://www.jocms.org/index.php/imj/article/view/349 |
Similar Items
-
Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
by: Nur Gokhan, et al.
Published: (2022-11-01) -
Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins
by: Foight, Glenna W., et al.
Published: (2017) -
Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
by: Md. Saddam, et al.
Published: (2024-01-01) -
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins
by: Clara Alcon, et al.
Published: (2021-07-01) -
Anti-apoptotic BCL-2 family proteins in acute neural injury
by: UJVAL eANILKUMAR, et al.
Published: (2014-09-01)